InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Temperato John, Chief Executive Officer. Director active across 1 companies, notably 9 METERS BIOPHARMA, INC.. Aggregated, 6 disclosures have been logged. Total volume traded: €209k. The latest transaction was disclosed on 18 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€21,27950,000 shares@ €0.425610.2% of flow
Common Stock
SEC:0001578563-22-000017:0·
Ideal exit: 12 Feb 2023 (T+270)
€50,025100,000 shares@ €0.500323.9% of flow
Common stock
SEC:0001551986-22-000021:0·
Ideal exit: 28 Nov 2022 (T+270)
€46,37350,000 shares@ €0.927567.4% of flow
Common stock
SEC:0001551986-21-000120·
Ideal exit: 15 Aug 2022 (T+270)
€46,37350,000 shares@ €0.927522.2% of flow
Common stock
SEC:0001551986-21-000120:0·
Ideal exit: 15 Aug 2022 (T+270)
€22,43025,000 shares@ €0.897232.6% of flow
Common stock
SEC:0001551986-21-000095·
Ideal exit: 15 May 2022 (T+270)
€22,43025,000 shares@ €0.897210.7% of flow
Common stock
SEC:0001551986-21-000095:0·
Ideal exit: 15 May 2022 (T+270)
6 of 6 declarations
About Temperato John
John Temperato is Chief Executive Officer at 9 Meters Biopharma, Inc. He is responsible for the strategic direction of the company and the management of daily operations. His leadership is essential for achieving the company's growth and innovation objectives.
